Donald Notman
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Donald Notman is Chief Operating Officer at Ocular Therapeutix, Inc. since 2026.
Formerly, Mr. Notman was Managing Director & Head-Private Capital Markets at Leerink Partners LLC.
From 2014 to 2017, Mr. Notman was Chief Financial Officer & Senior Vice President at Thrasos Therapeutics, Inc. Education includes an undergraduate degree from Middlebury College and an MBA from Tuck School of Business at Dartmouth.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 184.662 ( 0,09% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Operationeel Directeur | 29-08-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Financieel Directeur/CFO | 01-03-2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau